Yitu unveils a new AI cancer detection tool, hailing these products as "great creations of human history"

Yitu Technology, one of China's leading artificial intelligence companies, has introduced a new AI cancer screening tool designed to reduce the workload and improve the diagnostic capabilities of radiologists of the whole world.

Unveiled Wednesday at the annual conference of the North American Radiology Society in Chicago, this tool allows machines to pose in a few seconds recommendations for diagnosis and treatment on the basis of a complete set of information, including patient scans, ultrasounds, pathology samples, genetic data and records.

The tool highlights an area of ​​AI application in which China is strong – partly because of the country's AI campaign, but also because the country is home to one in five patients in the world, according to government statistics.

"China is progressing rapidly and leading in the application of AI to the health sector," Cathy Fang Cong, vice president of Yitu Healthcare, said on the sidelines of the launch. "Medical AI products capable of meeting clinical needs with reliable performance and being replicated quickly are excellent creations of human history."

The Shanghai-based start-up is one of dozens of AI companies that have emerged in recent years to apply their expertise in computer vision and natural language processing to cancer detection. Last November, an intelligent robot developed by iFlytek, a company listed in Shenzhen, passed the country's national written qualification exam for doctors. Founded in 2012, Yitu's investors include Sequoia Capital, Yunfeng Capital and Hillhouse Capital.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Young AI companies collaborate with a hospital to reduce the number of cancer deaths using massive data"data-reactid =" 27 "> A start-up partner of a hospital partner to reduce cancer deaths with the help of massive data

Yitu's intelligent diagnostic and treatment platform can help doctors diagnose and treat lung and breast cancers, the most common forms of the disease in men and women in China, respectively, according to the company. Research is underway to expand the cervical, colorectal and gastric cancer detection platform.

Last November, Tencent Holdings, operator of the ubiquitous WeChat social messaging platform, was hand-picked by Beijing to drive applications of artificial intelligence in healthcare. He has since teamed up with more than 100 triple-A hospitals nationwide.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Meanwhile, the main operator of Chinese search engine Baidu has moved to open-source AI technologies that can help pathologists detect breast cancer, while Alibaba Group Holding, China's largest e-commerce company and the South China Morning Post, announced partnerships with hospitals for intelligent diagnostic platforms. "data-reactid =" 30 "> Meanwhile, China's leading search engine operator, Baidu, has opted for open-source AI technologies that allow pathologists to detect breast cancer, while Alibaba Group Holding, the largest e-commerce company in China and the owner of South China Morning Post, announced partnerships with hospitals for intelligent diagnostic platforms.

At the RSNA conference, Yitu also unveiled a 4D imaging system for thoracic CT, offering real-time imaging of the lungs for the detection of nodules and other lesions, including cystic, band and plate shadows . This tool is designed as a "clinical assistant" to reduce the workload of radiologists.

"This system is a breakthrough for thoracic CT scans because it is the first in the world to allow detection of all lesion dimensions," said Cong, adding that until now, others focused only on nodules.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Tencent to merge Doctorwork with Trusted Doctors to expand its online and offline medical network in China"data-reactid =" 33 "> Tencent to merge Doctorwork with Trusted Doctors to create its online and offline medical network in China

Yitu has a team of more than 400 certified doctors and has links to more than 200 nationally triple-A hospitals for experimental use in a clinical setting. In June, Yitu announced an agreement with West China Hospital in Chengdu on lung cancer research, which would give him access to about 28,000 real cases – the largest database of its kind in the world – for studies. diagnosis of AI.

According to the National Cancer Institute, there are more than 780,000 new cases of lung cancer in China each year. Zhou Chunwu, deputy dean of the anti-cancer hospital of the Chinese Academy of Medical Sciences, said Zhou Chunwu, a leading factor behind the high incidence of cancer, has said Zhou Chunwu, deputy dean of the Chinese Academy of Medical Sciences. this month.

Yitu is currently participating in a national cancer screening program currently being rolled out across the country. The company opened an office in Singapore earlier this year with the goal of strengthening its global expansion. Countries in Southeast Asia will likely become the first step, where regulators share an "open and positive" attitude toward AI-assisted health care, Cong said.

Yitu's lung cancer control system is expected to be approved by the Chinese Food and Drug Administration for commercial use next year, said Ni Hao, director general of public health of Yitu, in an interview with June.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "This article Yitu unveils a new AI cancer detection tool, hailing these products as "great creations of human history" first appeared on Morning of South China"data-reactid =" 38 "> This article, Yitu, unveils a new tool for detecting cancer of avian influenza, hailing these products" great creations of human history "have been published for the first time at the South China Morning Post

<p class = "canvas-atom-canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "For the latest news from the Morning of South China download our mobile app. Copyright 2018. "data-reactid =" 39 "> For the latest news from the South China Morning Post, download our mobile application Copyright 2018.